Oil Is the New Gold
Health Care: Drugs
Sanofi (SNY: NYSE)
$53.40 -1.16 | -2.13%
06/19/13 - 04:02 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 53.40 |
| 52 Week High | 55.94 |
| 52 Week Low | 35.50 |
| Avg. Daily Vol. (Mil) | 2.12 |
| Beta (3 year) | 1.00 |
| Share Related Items | |
| Mkt Cap (Mil) | 143,210.13 |
| Shares Out (Mil) | 2,681.84 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 2.40 |
| Annual Dividend | 1.30 |
| Payout Ratio | 82.00 |
| Financial Strength | |
| Quick Ratio | n.a. |
| Current Ratio | n.a. |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | 25.90 |
| Price/Sales | 3.10 |
| Price/Book | 0.00 |
| Price/Cash Flow | 10.90 |
| Per Share Data | |
| Earnings | 2.06 |
| Sales | 17.24 |
| Book Value | 0.00 |
| Cash Flow | 4.91 |
| Business Summary | |
|---|---|
| Sanofi is a healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. The Company also discovers, develops and distributes therapeutic solutions. | |
| General Information | |
| 54, Rue La Botie
Paris, 75008 |
|
| www.sanofi-aventis.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 111974 | |
| CEO: Christopher Viehbacher | |
| Short Interest | |
| Current Month (Mil) | 2.51 |
| Previous Month (Mil) | 3.01 |
| Short Interest Ratio (Days) | 2.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | 0.00 |
| Return on Investments | n.a. |
| Profitability | |
| Gross Margin | 68.60 |
| EBIT Margin | 5.00 |
| Profit Margin | 12.30 |
Portfolios with SNY
- Portfolio NameUser Type
- ProWarren Buffett
- ContributorTechnical Setups for the We...
- ContributorStocks Rising On Unusual Vo...
- ProKen Fisher - Fisher Investm...
- ContributorHigh Volume Technicals for ...
- ContributorRocket Stocks for the Week ...
- Contributor9 Stocks to Buy for a Europ...
- ContributorDrugs Facing FDA Approval i...
- Contributor7 Big-Pharma Stocks With Un...
- UserLong Term Stock Picks
Latest SNY Headlines from TheStreet
- 5 Health Care Stocks Pushing The Sector Higher 06.17.13 | 01:06 pm
- Sanofi Stock Buy Recommendation Reiterated (SNY) 06.14.13 | 10:06 am
- Sanofi (SNY): Today's Featured Health Care Winner 06.12.13 | 05:06 pm
- 5 Drugs Stocks Dragging The Industry Down 06.11.13 | 01:06 pm
- Sanofi Stock Buy Recommendation Reiterated (SNY) 06.04.13 | 10:06 am
- Sanofi Stock Hits New 52-Week High (SNY) 05.28.13 | 11:05 am
- Sanofi Stock Buy Recommendation Reiterated (SNY) 05.23.13 | 10:05 am
- Sanofi (SNY): Today's Featured Drugs Laggard 05.20.13 | 05:05 pm
- 5 Stocks Underperforming Today In The Drugs Industry 05.20.13 | 01:05 pm
- Sanofi Stock Buy Recommendation Reiterated (SNY) 05.13.13 | 10:05 am
Press Releases for SNY
- Leading Experts In Parenting, Education And Medicine Partner To Launch Head Lice Awareness Initiative - PR Newswire 06.17.13 | 08:06 am
- New Four-Strain Influenza Vaccine From Sanofi Pasteur Now Licensed By FDA For Broad Age Range Of Children And Adults - PR Newswire 06.10.13 | 07:06 am
- Sanofi US Announces Winner Of 2013 Data Design Diabetes Innovation Challenge -- Prove It! - PR Newswire 06.04.13 | 10:06 am
- Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma And Allergy Awareness Month - PR Newswire 05.16.13 | 08:05 am
- New Gold Bond® No Mess Powder Spray Introduced By Sanofi's Chattem - PR Newswire 05.06.13 | 03:05 pm
- Sanofi US And Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents "Strength In Numbers" - PR Newswire 05.06.13 | 08:05 am
- NextBio Announces Translational Medicine Partnership With Sanofi - PR Newswire 04.30.13 | 08:04 am
- U.S. FDA Grants Fast-Track Designation To Sanofi Pasteur And KaloBios' Novel Biologic Candidate For Pseudomonas Aeruginosa - PR Newswire 04.23.13 | 08:04 am
- New Allegra® Anti-Itch Cream Introduced By Sanofi's Chattem - PR Newswire 04.11.13 | 08:04 am
- Basketball Legend Lisa Leslie Teams Up With Allegra® To Help Families Enjoy Outdoor Workouts This Allergy Season - PR Newswire 03.28.13 | 10:03 am
Partner Headlines for SNY
- Top-Performing Dividend Payers in Health Care with the Most Upside Potential (AET, ENSG, QCOR) - Benzinga 06.08.13 | 12:06 pm
- FDA Panel Positive on GSK's Avandia - Analyst Blog - Zacks 06.07.13 | 10:06 pm
- GSK/Genmab Report Positive Arzerra Data - Analyst Blog - Zacks 05.31.13 | 11:05 pm
- Clearing The Air On The Sanofi-Regeneron Asthma Drug Trial - Seeking Alpha 05.28.13 | 09:05 am
- Encouraging News for Peregrine Pharma - Analyst Blog - Zacks 05.24.13 | 01:05 am
- Will Influenza A H7N9 Generate Opportunities For Pharma? - Seeking Alpha 05.21.13 | 09:05 am
- Sanofi (SNY) Ex-Dividend Date Scheduled for May 06, 2013 - NASDAQ 05.03.13 | 01:05 pm
- Ampio Pharma Initiates Phase III, Investors Extend Momentum - Seeking Alpha 05.03.13 | 09:05 am
- Weak Data Hamstring Stocks; Regeneron Pharmaceuticals Soars - Investor's Business Daily 05.01.13 | 12:05 pm
- Regeneron's Flagship Drug Treats Blindness In Seniors - Investor's Business Daily 04.11.13 | 05:04 pm
